Ertapenem Market
Global Ertapenem Market Size, Share & Trends Analysis Report by Type (Purity: Above 98% and Purity: Above 99%), and by Application (Injection and Tablet) Forecast 2022-2028 Update Available - Forecast 2024-2030
The global ertapenem market is anticipated to grow at a significant CAGR during the forecast period. Ertapenem is an antibiotic that is used to treat bacterial infections of the skin, lungs, stomach, pelvic, and urinary tract. Ertapenem is also prescribed for patients undergoing certain types of surgery that pose a risk of infection. In addition, it is being used in the treatment of infections of the abdomen, the lungs, the upper part of the female reproductive system, and diabetic foot. Increasing prevalence of these infection among population is further lead to the market growth. In addition, the new product launches by players operating in the market is going to accelerate the growth of the market during the forecast period. For instance, in May 2021, Dr. Reddy's Laboratories Ltd. and its subsidiaries, collectively referred to as Dr. Reddy's, launched a new of Ertapenem for Injection, a therapeutic equivalent generic version of INVANZ (ertapenem for injection), approved by the US Food and Drug Administration (USFDA). Furthermore, the company has expanded its strategic collaboration with Gland Pharma, which has led the execution of this launch.
Impact of COVID-19 Pandemic on Global Ertapenem Market
The COVID-19 pandemic has impacted the global economy due to slowdown in manufacturing of various industries. However, COVID-19 is an unprecedented global public health emergency that has affected almost every industry and is expected to have a long-term impact on industry growth over the forecast period.
Segmental Outlook
The global ertapenem market is segmented based on type, and application. Based on the type, the market is segmented into purity: less-than or equal to 99% and purity: above 99%. Based on application the market is sub-segmented into injection and tablet.
Global Ertapenem Market Share by Application, 2020 (%)
The Injection Segment is Anticipated to Hold a Prominent Share in the Global Ertapenem Market
Based on application, the injection segment is likely to hold largest share in the market during the forecast period. Ertapenem injection is used to help cure infections caused by bacteria, such as pneumonia and urinary tract, skin, diabetic foot, gynecological, pelvic, and abdominal (stomach area) infections. It is being used to avoid infection after surgical treatment. millions.
Regional Outlooks
The key regional markets of North America, Europe, Japan, China, India, and Southeast Asia. During the forecast period, North America is expected to account for a sizable share of the market. The region's stringent regulatory standards and Ertapenem Injection incentivizing policies are prompting hospitals and clinics to implement Ertapenem Injection solutions.
Global Ertapenem Market Growth, by Region 2022-2028
The Asia-Pacific Region is Estimated to Hold the Major Share in the Global Ertapenem Market
The Asia-Pacific is anticipated to hold a prominent share in the market during the forecast period. The rising infection such as pneumonia and urinary tract, skin, diabetic foot, gynecological, and others in major economies of Asia-Pacific region is the prominent factor that has surged the demand for Ertapenem in injection and tablet form. Due to increasing such infections among population, the healthcare expenditure by them is also increasing that is motivating market players to increase their R&D activities for novel drugs.
Market Players Outlook
The major companies serving the global Ertapenem market include Kopran Ltd., Canagen Pharma Inc., Conder Co., Taiwan Savior Lifetec Corp., Pfizer Inc., Merck Co. & Inc., Sumitomo Dainippon Pharma Co., Ltd., Xiamen Amoipharm Chem. Co. Ltd., Fuan Pharmaceutical (Grp.) Co. Ltd., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2018, Endo International PLC announced that one of its operating companies, Par Pharmaceutical (Par), has begun selling an authorised generic version of Merck's INVANZ (ertapenem for injection). Endo Ventures Ltd., an Endo subsidiary, recently signed an exclusive supply and distribution agreement with Merck & Co., Inc., enabling Par to launch and market an authorised generic version of the medicine.
The Report Covers
- Market value data analysis of 2020 and forecast to 2027.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global Ertapenem market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on The Global Ertapenem Market
• Recovery Scenario of Global Ertapenem Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Conder Co.
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Canagen Pharma Inc.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Fuan Pharma (Grp.) Co. Ltd.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Kopran Ltd.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Taiwan Savior Lifetec Corp.
3.5.1. Overview
3.5.2. Financial Analysis
3.5.3. SWOT Analysis
3.5.4. Recent Developments
3.6. Key Strategy Analysis
3.7. Impact of Covid-19 on Key Players
4. Market Segmentation
4.1. Global Ertapenem Market by Type
4.1.1. Purity: Less than or Equal to 99%
4.1.2. Purity: Above 99%
4.2. Global Ertapenem Market by Application
4.2.1. Injection
4.2.2. Tablet
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.2. 6.1. Taiwan Savior Lifetec Corp.
6.3. Xiamen Amoipharm Chem. Co. Ltd.
6.4. Fuan Pharmaceutical (Grp.) Co. Ltd.
6.5. Pfizer Inc.
6.6. Merck Co. & Inc.
6.7. Sumitomo Dainippon Pharma Co., Ltd.
1. GLOBAL ERTAPENEM MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL PURITY: LESS-THAN OR EQUAL TO 99% ERTAPENEM MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL PURITY: ABOVE 99% ERTAPENEM MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL ERTAPENEM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
5. GLOBAL ERTAPENEM BY INJECTION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL ERTAPENEM BY TABLET MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL ERTAPENEM MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
8. NORTH AMERICAN ERTAPENEM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
9. NORTH AMERICAN ERTAPENEM MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
10. NORTH AMERICAN ERTAPENEM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
11. EUROPEAN ERTAPENEM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
12. EUROPEAN ERTAPENEM MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
13. EUROPEAN ERTAPENEM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
14. ASIA-PACIFIC ERTAPENEM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
15. ASIA-PACIFIC ERTAPENEM MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
16. ASIA-PACIFIC ERTAPENEM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
17. REST OF THE WORLD ERTAPENEM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
18. REST OF THE WORLD ERTAPENEM MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
19. REST OF THE WORLD ERTAPENEM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL ERTAPENEM MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL ERTAPENEM MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL ERTAPENEM MARKET, 2021-2028 (%)
4. GLOBAL ERTAPENEM MARKET SHARE BY TYPE, 2021 VS 2028 (%)
5. GLOBAL PURITY: LESS-THAN OR EQUAL TO 99% ERTAPENEM MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL PURITY: ABOVE 99%ERTAPENEM MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL ERTAPENEM MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
8. GLOBAL ERTAPENEM BY INJECTION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL ERTAPENEM BY TABLET MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL ERTAPENEM MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. US ERTAPENEM MARKET SIZE, 2021-2028 ($ MILLION)
12. CANADA ERTAPENEM MARKET SIZE, 2021-2028 ($ MILLION)
13. UK ERTAPENEM MARKET SIZE, 2021-2028 ($ MILLION)
14. FRANCE ERTAPENEM MARKET SIZE, 2021-2028 ($ MILLION)
15. GERMANY ERTAPENEM MARKET SIZE, 2021-2028 ($ MILLION)
16. ITALY ERTAPENEM MARKET SIZE, 2021-2028 ($ MILLION)
17. SPAIN ERTAPENEM MARKET SIZE, 2021-2028 ($ MILLION)
18. REST OF EUROPE ERTAPENEM MARKET SIZE, 2021-2028 ($ MILLION)
19. INDIA ERTAPENEM MARKET SIZE, 2021-2028 ($ MILLION)
20. CHINA ERTAPENEM MARKET SIZE, 2021-2028 ($ MILLION)
21. JAPAN ERTAPENEM MARKET SIZE, 2021-2028 ($ MILLION)
22. SOUTH KOREA ERTAPENEM MARKET SIZE, 2021-2028 ($ MILLION)
23. REST OF ASIA-PACIFIC ERTAPENEM MARKET SIZE, 2021-2028 ($ MILLION)
24. REST OF THE WORLD ERTAPENEM MARKET SIZE, 2021-2028 ($ MILLION)
